The Department of Justice is seeking public input on the "distinct economic impacts" of its plan to reclassify pot. Big money is at stake. Read More

The “next big thing” in the booming psychotropics industry? Tourist packages predicated on LSD, magic mushrooms, and other psychedelic drugs. Read More

The recent decision by the U.S. Drug Enforcement Administration (DEA) to shift cannabis to Schedule III is on its way to becoming reality. Read More

The DEA's reclassification of marijuana would substantially enhance the profitability and social acceptance of weed companies. Read More

A new study released last week demolishes the cliche that marijuana turns its users into paranoid and lazy loafers. Read More

The Bay State is a microcosm of marijuana’s increasing popularity throughout the country, especially in customer-rich Northeastern states. Read More

A major pollster chose the global marijuana holiday as an opportune time to release new findings that confirm weed's increasing acceptance. Read More

The medical use of marijuana has skyrocketed in the U.S. in recent years, underscoring the vast growth potential of cannabis. Read More

Psychedelic substances are undergoing a renaissance and they’re becoming a major investment story in 2024. Let’s review the latest trends. Read More

Despite increasing legalization of marijuana, pot arrests have risen in frequency. Here’s what it means for investors. Read More